Hepatic Resection for Hepatocellular Carcinoma in Patients With Portal Hypertension: A Long-Term Benefit Compared With Transarterial Chemoembolization and Thermal Ablation
The optimal treatment for hepatocellular carcinoma (HCC) in cirrhotic patients with portal hypertension (PHT) is still controversial. The objective of this study is to compare HCC patients with PHT treated with hepatic resection to those treated with transarterial chemoembolization (TACE) or thermal...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Wolters Kluwer Health
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554177/ |